Reduction of skin irritation and resistance during electrotransport

• US 5,624,415 A
• Filed: 04/24/1995
• Issued: 04/29/1997
• Est. Priority Date: 04/24/1995
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Cormier, Michel J. N., Phipps, Joseph B., Johnson, Juanita, Ledger, Philip W., Chao, Stella
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US08/427,336
• Time in Patent Office: 736 Days
• Field of Search: 604/890.1, 604/20-21, 604/290, 604/49, 604/50, 604/65-66, 607/149-153, 128/783, 128/632
• US Class Current: 604/290
• CPC Class Codes: A61N 1/0432 Anode and cathode
• CPC Class Codes: A61N 1/0436 Material of the electrode
• CPC Class Codes: A61N 1/0448 Drug reservoir

Abstract

An electrotransport delivery device utilizing reservoir buffering at a select pH ranges in order to reduce skin irritation and skin resistance is provided. Cathodic reservoirs are buffered to a pH of less than about 4, preferably to a pH in the range of about 2 to 4, while anodic reservoirs are buffered to a pH above about 4, preferably to a pH in the range of about 4 to 10. Another electrotransport delivery device utilizes a potassium sensor to monitor potassium efflux from the skin. Potassium efflux above a certain predetermined level has been found to be a precursor to skin irritation/erythema. Operation of the device is modified (eg, terminated) when the predetermined potassium efflux level is sensed.

Claims

1. In a method of delivering an agent by electrotransport through a body surface, said method including placing an anodic reservoir and a cathodic reservoir of an electrotransport agent delivery device in ion-transmitting relation with said body surface, at least one of the reservoirs containing the agent to be delivered, applying an electrical potential across the anodic and cathodic reservoirs in order to deliver the agent through the body surface by electrotransport;

the improvement comprising during said electrotransport agent delivery, performing a step selected from the group consisting of;

(a) maintaining, during electrotransport agent delivery the anodic reservoir at a pH above 4 and maintaining, during electrotransport agent delivery, the cathodic reservoir at a pH below 4; and

(b) maintaining, during electrotransport agent delivery, the cathodic reservoir at a pH below 4.

2. The method of claim 1, wherein the anodic reservoir pH is maintained within the range of 4 to 10.

3. The method of claim 1, further comprising buffering said anodic reservoir.

4. The method of claim 3, wherein said anodic reservoir is buffered with an anionic buffer.

5. The method of claim 3, wherein the anodic reservoir is buffered with a buffer selected from the group consisting of citric acid and EDTA.

6. The method of claim 1, said method having an affect selected from the group consisting of lowering electrical resistance of the body surface during the electrotransport agent delivery, lessening irritation to the body surface caused by the electrotransport agent delivery, lessening erythema to the body surface caused by the electrotransport agent delivery, lessening damage to the body surface caused by the electrotransport agent delivery, and combinations thereof.

7. The method of claim 1, wherein the cathodic reservoir pH is maintained in the range of 2 to 4.

8. The method of claim 1, further comprising buffering said cathodic reservoir.

9. The method of claim 8, wherein said cathodic reservoir is buffered with a cationic buffer.

10. The method of claim 9, wherein said cationic reservoir is buffered, during electrotransport agent delivery, with a cationic buffer selected from the group consisting of histidine, lysine, arginine, aspartic acid, glutamic acid, cysteine, tyrosine, and combination thereof.

11. The method of claim 8, wherein said cathodic reservoir is buffered with:

(a) a polymeric buffer selected from the group consisting of vinylpyrrolidone/quaternized dimethylamino-ethylmethacrylate copolymers, vinylcaprolactam/vinylpyrrolidone/dimethylamino ethylmethacrylate terpolymers, polyvinylpyrrolidone, and methacrylate/divinyl benzene copolymers;

or

(b) a buffer selected from the group consisting of aspartic acid, glutamic acid, citric acid, succinic acid, phosphoric acid, acetic acid, EDTA, lactic acid, benzoic acid, tartaric acid, maleic acid, fumaric acid, sulfuric acid, formic acid, malic acid, malonic acid, glutaric acid, and adipic acid.

12. The method of claim 8 wherein the cathodic reservoir is buffered with a buffer selected from the group consisting of citric acid and EDTA.

13. The method of claim 1, including operating a secondary electrode, which secondary electrode is in communication with the anodic reservoir or the cathodic reservoir, by reversibly oxidizing and/or reducing the secondary electrode in a manner effective to maintain the pH of said reservoir in communication with the secondary electrode.

14. The method of claim 1, wherein the cathodic reservoir contains the agent to be delivered and the method further comprises

(a) delivering the agent from the cathodic reservoir through the body surface by electrotransport;

and

(b) maintaining, during delivery of the agent, the anodic reservoir pH above about 4.

15. The method of claim 1, wherein the anodic reservoir contains the agent to be delivered and the method further comprises

(a) delivering the agent from the anodic reservoir through the body surface by electrotransport;

and

(b) maintaining, during delivery of the agent, the cathodic reservoir pH below about 4.

16. In a method of delivering an agent by electrotransport through a body surface, said method including placing an anodic reservoir and a cathodic reservoir of an electrotransport agent delivery device in ion-transmitting relation with said body surface, at least one of the reservoirs containing the agent to be delivered, applying an electrical potential across the anodic and cathodic reservoirs in order to deliver the agent through the body surface by electrotransport;

the improvement comprising during said electrotransport agent delivery, performing a step selected from the group consisting of;

(a) maintaining, during electrotransport agent delivery, the anodic reservoir at a pH above 4, wherein said anionic reservoir is buffered with an anionic buffer selected from the group consisting of histidine, lysine, arginine, aspartic acid, glutamic acid, cysteine, tyrosine, and combinations thereof; and

(b) maintaining, during electrotransport agent delivery, the cathodic reservoir t a pH below 4.

17. In a method of delivering an agent by electrotransport through a body surface, said method including placing an anodic reservoir and a cathodic reservoir of an electrotransport agent delivery device in ion-transmitting relation with said body surface, at least one of the reservoirs containing the agent to be delivered, applying an electrical potential across the anodic and cathodic reservoirs in order to deliver the agent through the body surface by electrotransport;

the improvement comprising during said electrotransport agent delivery, performing a step selected from the group consisting of;

(a) maintaining, during electrotransport agent delivery, the anodic reservoir at a pH above 4, wherein said anodic reservoir is buffered with a buffer selected from the group consisting of;

(i) aspartic acid, glutamic acid, succinic acid, phosphoric acid, acetic acid, lactic acid, boric acid, carbonic acid, monobasic sodium phosphate, benzoic acid, tartaric acid, maleic acid, fumaric acid, sulfuric acid, formic acid, malic acid, malonic acid, glutaric acid, and adipic acid;

(ii) tromethamine, triethanolamine, imidazole, ammonia, ethanolamine, diethanolamine, histidine, lysine, and arginine;

(iii) calcium chloride dihydrate, triethanolamine hydrochloride, magnesium chloride heptahydrate, diethanolamine hydrochloride, ammonium chloride, ethanolamine hydrochloride, potassium chloride, and sodium chloride;

(iv) 2-(N-morpholino)-ethane sulfonic acid, 1,4-piperazine-bis-(ethanesulfonic acid), N-2-acetamido iminodiacetic acid, N-2(2-acetamido)-2-aminoethane sulfonic acid, N,N-bis(2-hydroxyethyl)-2-aminoethane sulfonic acid, 2-(N-morpholino) -propane sulfonic acid, N-tris hydroxymethyl) methyl-2-aminoethane sulfonic acid, N-2-hydroxyethyl piperazine-N'"'"'-2-ethane sulfonic acid, 4-(2-hydroxyethyl) -1-piperazine propane sulfonic acid, N-tris(hydroxymethyl) methyl-2-aminopropane sulfonic acid, 2-cyclohexylamino-1-ethane sulfonic acid, 3-cyclohexylamino-1-propanesulfonic; and

(v) polyacrylic acid, polymethacrylic acid, poly(styrene maleic anhydride), methacrylic/divinyl benzene copolymers, poly(2-acrylamido-2-methylpropane sulfonate), copolymers of acrylic acid and long chain acrylate esters, and poly(methylvinyl ether-maleic acid); and

(b) maintaining, during electrotransport agent delivery, the cathodic reservoir at a pH below 4.